Papers
31
Total Citations
538
H-Index
14
About
Zhe Tian is a prominent urological surgeon and health services researcher whose work sits at the intersection of surgical oncology, robotic surgery, and population-based outcomes research. With a focus on major uro-oncological procedures—particularly radical prostatectomy, radical cystectomy, and partial nephrectomy—Tian has made substantial contributions to understanding how surgical approach, patient characteristics, and hospital-level factors influence perioperative outcomes, costs, and oncological efficacy. Tian's most impactful work includes a nationally representative assessment of robot-assisted surgery adoption across the United States, which garnered 63 citations and illuminated the growing financial burden associated with robotic procedures. His research has consistently interrogated the real-world trade-offs between open and robotic techniques, examining variables such as obesity, advanced patient age, pelvic lymph node dissection extent, pain management, and length of stay—work collectively cited over 250 times. Notably, his 2021 study demonstrating the feasibility of robot-assisted radical prostatectomy in patients aged 75 and older has provided clinically meaningful guidance for surgical decision-making in elderly populations. By leveraging large databases including SEER-Medicare and the National Inpatient Sample, Tian has shaped evidence-based perspectives on surgical technology adoption, equity, and value in modern uro-oncological care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3In-hospital length of stay after major surgical oncological procedures44 citations · 2018
- 4
- 5
- 6
- 7
- 8
- 9Partial nephrectomy in frail patients: Benefits of robot-assisted surgery20 citations · 2021
- 10